The evolution of Good Clinical Practice (GCP) in Denmark.
Influence of international GCP standards and harmonization efforts.
Pre-existing ethical and scientific requirements for drug trials.
Purpose:
To outline the historical development and current status of Good Clinical Practice (GCP) in Denmark.
To highlight Denmark's contributions to international GCP guidelines.
To assess Denmark's preparedness for upcoming EU regulations on medicinal product trials.
Summary:
Denmark's adoption of Good Clinical Practice (GCP) evolved from existing ethical and scientific standards, with significant international collaboration.
The establishment of the Danish GCP Society fostered interdisciplinary cooperation and awareness.
Denmark is well-prepared for new EU regulations on medicinal product trials.
Impact:
Increased awareness and understanding of Good Clinical Practice (GCP) in Denmark.
Strengthened cooperation among Danish health authorities, industry, and regulatory bodies.
Significant Danish contributions to international GCP development and harmonization.